Simmunext Biotherapeutics:
a new approach in the fight against cancer
Simmunext Biotherapeutics is developing
immunofilaments as novel cancer therapeutics
Company
Simmunext Biotherapeutics uses its proprietary polymer-based nanotechnology platform to mimic natural immune cell function.
Technology
Simmunext’ unique immunofilaments technology platform is rooted in many years of fundamental research on the role of the immune system in the development of cancer and other disorders.
At Simmunext we are dedicated to bringing new and out-of-the-box solutions in case a failing immune system causes cancer or other diseases.